SCHEMBL6188069

SCHEMBL6188069

CC(=N)N1CCC(Oc2ccc(N(C(CC(=O)NC3CCCCC3)c3nc4cc(C(=N)N)ccc4[nH]3)S(=O)(=O)CC(=O)O)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.54
F2 P00734 1/20 0.52
KCNH2 Q12809 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6187309 0.99 F10 (0.54) F10F2KCNH2
Hydrochloric Acid SCHEMBL6188085 0.87 F10 (0.56) F10F2KCNH2
SCHEMBL6191487 0.85 F10 (0.55) F10
Hydrochloric Acid SCHEMBL6189998 0.84 F10 (0.56) F10
SCHEMBL6187873 0.80 F10 (0.54) F10
Hydrochloric Acid SCHEMBL6190851 0.79 F10 (0.55) F10
Hydrochloric Acid SCHEMBL6188336 0.78 F10 (0.49) F10
Hydrochloric Acid SCHEMBL6191519 0.76 F10 (0.60) F10
SCHEMBL6190498 0.73 F10 (0.55) F10
Hydrochloric Acid SCHEMBL6189441 0.72 F10 (0.56) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070714-A9 AMIDINE COMPOUNDS JAPAN TOBACCO INC. (JP) 2005-10-19 EP claimed
US-20040006099-A1 Amidine compounds JAPAN TOBACCO INC. 2004-01-08 US claimed
EP-1070714-A1 AMIDINE COMPOUNDS JAPAN TOBACCO INC. (JP) 2001-01-24 EP claimed
EP-1070714-A9 AMIDINE COMPOUNDS JAPAN TOBACCO INC. (JP) 2005-10-19 EP disclosed
US-20040006099-A1 Amidine compounds JAPAN TOBACCO INC. 2004-01-08 US disclosed
US-6562828-B1 Novel amidine compound having a blood coagulation factor Xa inhibitory activity JAPAN TOBACCO INC. (JP) 2003-05-13 US disclosed
EP-1070714-A1 AMIDINE COMPOUNDS JAPAN TOBACCO INC. (JP) 2001-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006099-A1 Amidine compounds F2, SERPINC1, F12 F10 16/4885F2 1/4885KCNH2 1760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.